Price Target Update on Amyris (NASDAQ:AMRS)

Amyris (NASDAQ:AMRS) : Currently there are 2 street experts covering Amyris (NASDAQ:AMRS) stock. The most bullish and bearish price target for the stock is $4 and $1 respectively for the short term. The average price target of all the analysts comes to $2.63. The estimated standard deviation from the target is $1.94.

Other Equity analysts have also commented on the company shares. Brokerage firm Cowen & Company maintains its rating on Amyris (NASDAQ:AMRS). As per the latest information, the brokerage house lowers the price target to $2 per share from a prior target of $2.5. The shares have been rated Market Perform. The rating by the firm was issued on March 10, 2016.

Amyris (NASDAQ:AMRS): On Thursdays trading session , Opening price of the stock was $0.435 with an intraday high of $0.435. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $0.39. However, the stock managed to close at $0.4, a loss of 3.38% for the day. On the previous day, the stock had closed at $0.414. The total traded volume of the day was 2,277,520 shares.

The company shares have dropped -78.07% from its 1 Year high price. On Jul 16, 2015, the shares registered one year high at $2.62 and the one year low was seen on Jun 22, 2016. The 50-Day Moving Average price is $0.59 and the 200 Day Moving Average price is recorded at $1.15. On the companys insider trading activities, Doerr L John, director of Amyris, Inc., executed a transaction worth $208,600 on June 14, 2016. A total of 200,577 shares were purchased at an average price of $1.04. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.

Amyris, Inc. is a renewable products company. The Company is focused on providing sustainable alternatives to a range of petroleum-sourced products used in consumer care, specialty chemical and transportation fuel markets around the world. The Company developed microbial engineering and screening technologies that modify the way microorganisms process sugars. The Company using its industrial bioscience technology to design microbes, primarily yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into renewable hydrocarbons. The Company has focused its commercialization efforts on a renewable hydrocarbon molecule called farnesene (Biofene), which forms the basis for a range of products including emollients, flavors and fragrance oils and diesel fuel.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.